Genomictree Inc. (228760) — Cash Flow Reinvestment Rate
Genomictree Inc. (228760) has a Cash Flow Reinvestment Rate of 3.71x as of December 2022, reinvesting ₩15.89 Billion (capex ₩1.82 Billion plus investments ₩14.07 Billion) from operating cash flow of ₩4.29 Billion. Explore cash efficiency ratio of Genomictree Inc. to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genomictree Inc. Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Genomictree Inc. across 1 annual periods. Explore 228760 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Genomictree Inc. (2022–2022)
Year-by-year capital reinvestment analysis for Genomictree Inc.. For live market cap and broader valuation context, see Genomictree Inc. (228760) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.71x | ₩15.89 Billion | ₩4.29 Billion | ₩1.82 Billion | — |